Clinical trials
Phase 3 Cross Infection trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 3 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 3 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | 4 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Alexandria University | 1 |
| Colombian Neonatal Research Network | 1 |
| Federico II University | 1 |
| Hospital do Coracao | 1 |
| Hospitales Universitarios Virgen del Rocío | 1 |
| Janssen Research & Development, LLC | 1 |
| King Chulalongkorn Memorial Hospital | 1 |
| Medical University of Warsaw | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cross Infection | 21 |
| Community-Acquired Infections | 4 |
| Pneumonia, Bacterial | 4 |
| Pneumonia, Ventilator-Associated | 4 |
| Community-Acquired Pneumonia | 2 |
| Enterocolitis, Necrotizing | 2 |
| Abdominal Abscess | 1 |
| Acute Kidney Injury | 1 |
| Bacteremia | 1 |
| Bacterial Infections | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.